IVVD:NASDAQInvivyd, Inc. Analysis
Data as of 2026-05-22 - not real-time
$1.11
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Invivyd is trading at $1.11, well beneath its 20‑day (≈$1.35), 50‑day (≈$1.46) and 200‑day (≈$1.68) moving averages, with an RSI of 35.7 and a bearish MACD histogram, signaling short‑term momentum weakness and heightened volatility of roughly 94% coupled with a beta above 2, which amplifies market swings.
Despite the technical headwinds, the company posted a 22% year‑over‑year increase in PEMGARDA product revenue to $13.7 million, maintains an impressive 93% gross margin, and holds $184 million in cash against modest debt, supporting a strong‑buy consensus and a median 12‑month target of $10, though operating losses and negative free cash flow remain concerns.
Despite the technical headwinds, the company posted a 22% year‑over‑year increase in PEMGARDA product revenue to $13.7 million, maintains an impressive 93% gross margin, and holds $184 million in cash against modest debt, supporting a strong‑buy consensus and a median 12‑month target of $10, though operating losses and negative free cash flow remain concerns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical indicators show bearish momentum
- Upcoming clinical trial updates could shift sentiment
- Strong cash position provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 22% and high gross margins
- Progress in VYD2311 Phase III trial and product expansion
- Analyst consensus of strong‑buy and target price far above current level
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term market potential for antiviral monoclonal antibodies
- Robust cash reserves to fund R&D and commercialization
- Significant upside implied by target price versus current valuation
Key Metrics & Analysis
Financial Health
Revenue Growth21.60%
Profit Margin-138.90%
P/E Ratio-1.9
ROE-60.34%
ROA-29.59%
Debt/Equity4.25
P/B Ratio1.3
Op. Cash Flow$-78718000
Free Cash Flow$-50099752
Industry P/E27.3
Technical Analysis
TrendBearish
RSI35.7
Support$1.02
Resistance$1.58
MA 20$1.35
MA 50$1.46
MA 200$1.68
MACDBearish
VolumeIncreasing
Fear & Greed Index91.55
Valuation
Target Price$10.00
Upside/Downside800.90%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.33
Volatility94.64%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.